BIT Biotech Opportunities S/ DE000A3DCA95 /
NAV20/09/2024 | Diferencia+2.7600 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
---|---|---|---|---|
139.2900EUR | +2.02% | reinvestment | Equity Worldwide | HANSAINVEST ▶ |
NAV20/09/2024 | Diferencia+2.7600 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
---|---|---|---|---|
139.2900EUR | +2.02% | reinvestment | Equity Worldwide | HANSAINVEST ▶ |